Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CRISPR/Cas-related methods and compositions for treating herpes simplex virus

CRISPR/Cas-related methods and compositions for treating herpes simplex virus

US Patent 11001844 · Granted May 11, 2021

Estimated economic value: $43,463,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crispr/CAS-related methods and compositions for treating primary open angle glau2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and s2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
Phenothiazine derivatives and uses thereof2024
GNAQ targeted dsRNA compositions and methods for inhibiting expression2024
CRISPR/CAS-related methods and compositions for treating herpes simplex virus2023
CRISPR/CAS-related methods and compositions for treating herpes simplex virus2023
CRISPR/CAS-related methods and compositions for treating herpes simplex virus2023
Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and s2023
Phenothiazine derivatives and uses thereof2023
Therapeutic compositions2022